DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/a59ad0/indian_contract_ma) has announced the addition of the "Indian Contract Manufacturing - A Hot Opportunity" report to their offering.
The global pharmaceutical contract manufacturing industry has registered strong growth during the past few years. Amongst many other countries adopting the model, India has emerged as a market leader in pharma outsourcing. Outsourcing of drugs manufacturing provides many advantages for the pharmaceutical companies, such as enhanced production capacity, easier access to a large number of destination countries, and low scale up cost. Contract manufacturing will help the pharmaceutical companies to meet with the growing demand for new drugs and improve their core competencies.
According to this new research report Indian Contract Manufacturing - A Hot Opportunity, the demand for contract manufacturing services in India has been consistently rising due to the increasing cost pressure on pharmaceutical companies. The recent global economic slowdown was also a major factor for the adoption of contract manufacturing model. Leading pharma companies in the market are also looking at this model as a means to expand into the bio-similars and generics segment. With the changing economic scenario and the pressure of reducing drugs manufacturing cost, Indian contract manufacturing market is expected to grow at a CAGR of around 45.5% during 2011-2013.
The publisher has also found that pharma manufacturing process is highly developed in some of the prominent states in the country, such as Gujarat and Maharashtra. Thus, to present a clear picture, the publisher has incorporated the regional analysis of India along with the analysis of pharma market in the developed and emerging states. Drugs manufactured by the contract manufacturing companies in India are utilized for the local markets and exported to other major regions in the Asia-Pacific region, Middle East, and Africa.
The report provides an extensive research and prudent analysis of the Indian contract manufacturing industry. It gives an insight into the current and future market trends, and provides a brief overview of the regulatory environment in India regarding IP protection, export, and data protection. The report has also studied key contract manufacturers in the countries to help clients understand the overall market dynamics. The report will work as an investment guide for the clients looking to invest or outsource their manufacturing process in the Indian market.
Key Topics Covered:
1. Analyst View
2. Research Methodology
3. Market Overview
4. Regional Outlook and Scope
5. Market Analysis 6. Regulatory Environment
7. Competitive Analysis
Companies Mentioned:
- Piramal Healthcare Limited
- Dishman Pharmaceuticals and Chemicals Ltd.
- Dr. Reddy's Laboratories Ltd.
- Jubilant Life Sciences
- Wockhardt Ltd.
For more information visit http://www.researchandmarkets.com/research/a59ad0/indian_contract_ma